Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions
Hannah N Haq, Hafiz T. A. Khan, Haroon Rashid Chaudhry, Swathi Nimmala, Joseph Demidovich, Bhavani Nagendra Papudesi, Sai Deepika Potluri
Topics & Concepts
MedicineVaccinationCoronavirus disease 2019 (COVID-19)PandemicAnaphylaxisImmunologyPublic healthSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyAllergyIntensive care medicineDiseaseInternal medicinePathologyInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchDrug-Induced Adverse ReactionsHeparin-Induced Thrombocytopenia and Thrombosis